# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Finalizing a 510(k) premarket notification application for the T2Resistance® Panel planned to be filed with the U.S. Food and D...
https://www.tga.gov.au/resources/artg/459987
Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ:TTOO) with a Hold and raises the price target from $3 ...
T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.97)...
Marks Continued International Expansion Following Recent Hong Kong And Macau Entry; Aims To Improve Sepsis Care Globally, Says ...
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, ...